Author

B. Verdon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

C. Ward· 2 shared I. J. Haq· 2 shared A. C. M. Khan· 1 shared A. Guequen· 1 shared A. I. Gardner· 1 shared B. D. Baxter· 1 shared B. J. Thompson· 1 shared B. Tapia-Balladares· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

C. Ward

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Airway succinate chemosensing induces CFTR-dependent anion secretion and mucus clearance which is impaired in cystic fibrosis.

T. Apablaza, M. Barros-Poblete, L. Delpiano, S. Villanueva, A. Guequen, B. Tapia-Balladares, I. J. Haq, F. Tribinos, S. Hernandez-Rivas, B. Verdon, M. G. Biggart, Y. Sanchez, C. Ward, B. D. Baxter, D. Restrepo, , C. A. Flores

bioRxiv · Mar 26, 2024 · PreprintPhysiology

Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2

C. F. Hatton, R. A. Botting, M. E. Duenas, I. J. Haq, B. Verdon, B. J. Thompson, J. Stremenova Spegarova, F. Gothe, E. A. Stephenson, A. I. Gardner, S. Murphy, J. Scott, J. P. Garnett, S. Carrie, J. Powell, , C. J. A. Duncan

This study shows that delayed type I and III interferon responses in nasal epithelial cells allow SARS-CoV-2 replication, but pre-infection IFN treatment restricts virus and preserves barrier integrity.

bioRxiv · Feb 17, 2021Immunology